| Study |
Median Survival Time [days] |
Mean Bilirubin Decrease [mg/dL] |
| Reference |
Study Design |
N [PDT/Stent] |
PDT |
Stent |
Difference in means |
CI 95% |
p value |
PDT |
Stent |
Difference in means |
CI 95% |
p value |
| Dumoulin [48] |
Historical Control |
44 [24/20] |
297 |
168 |
129 |
2.29 - 255.71 |
0.05 |
-10.7 |
-5.8 |
-4.9 |
-8.73 - -1.07 |
0.01 |
| Ortner [43] |
RCT |
39 [20/19] |
493 |
98 |
395 |
172.07 - 617.93 |
0.00 |
-8.05 |
-0.95 |
7.1 |
-9.27 - -4.93 |
0.00 |
| Zoepf [44] |
RCT |
32 [16/16] |
630 |
210 |
420 |
296.94 - 543.06 |
0.01 |
-1.45 |
-1.2 |
0.25 |
-7.38 - +6.88 |
0.95 |
| Witzigmann [46] |
Controlled Cohort design |
124 [68/56] |
360 |
192 |
168 |
45.69 -290.31 |
0.01 |
-7.9 |
-4.3 |
-3.6 |
-6.83 - -0.37 |
0.03 |
| Kahaleh [49] |
Historical Control |
48 [19/29] |
486 |
222 |
264 |
11.41 - 516.59 |
0.04 |
-4.8 |
-6.5 |
1.7 |
+0.76 - +2.64 |
0.78 |
| Quyn [50] |
Controlled Cohort design |
40 [23/17*] |
425 |
169 |
256 |
59.81- 452.19 |
0.01 |
/ |
/ |
/ |
/ |
/ |
| Cheon [51] |
Historical Control |
143 [72/71] |
294 |
219 |
75 |
39.79 - 106.21 |
0.03 |
/ |
/ |
/ |
/ |
/ |
|